Cargando…
Monoclonal Antibodies for COVID-19 in X-linked Agammaglobulinemia: a Case Series
Autores principales: | Simard, Marie-Lee, Nadeau, Marc-Antoine, Gauthier, Amélie, Cros, Guilhem, Lavoie, Aubert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123548/ https://www.ncbi.nlm.nih.gov/pubmed/37093405 http://dx.doi.org/10.1007/s10875-023-01480-0 |
Ejemplares similares
-
X-Linked Agammaglobulinemia Case with TH Domain Missense Mutation in Bruton Tyrosine Kinase
por: Agrebi, Nourhen, et al.
Publicado: (2021) -
A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma
por: Iaboni, Aled, et al.
Publicado: (2021) -
Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
por: Ciuffreda, Laura, et al.
Publicado: (2021) -
Responses to SARS-CoV-2 Vaccines of Patients with Common Variable Immune Deficiencies and X-linked Agammaglobulinemia
por: Carrabba, Maria, et al.
Publicado: (2022) -
Splice-Correction Strategies for Treatment of X-Linked Agammaglobulinemia
por: Bestas, Burcu, et al.
Publicado: (2015)